How to Value a Startup in 2026
Startup valuation before profitability is not an appraisal; it is a negotiated price set by stage norms, revenue multiples, and competition for the deal. Pre-seed prices at $3M to $8M, seed at $10M to $25M, Series A at 15x to 30x ARR, and every number bends to growth rate and market heat. Run your own inputs through the startup valuation calculator as you read.
The uncomfortable truth first: at the earliest stages, your valuation is determined far more by what comparable companies raised at than by any formula. Methods below tell you where the anchor sits and how to move it.
What a Valuation Actually Is (Pre-Revenue Edition)
An early-stage valuation answers one practical question: how much of the company does this check buy? A $1M raise at $10M post-money sells 10 percent. That is the entire mechanical content of the number.
Which is why the same startup can be "worth" $6M in Kansas City and $12M in an SF competitive process. The company did not change; the competition for the deal did. Everything in this guide serves that lever: methods justify a number, momentum gets it accepted.
Two vocabulary items before the math, both covered in the fundraising glossary: pre-money vs post-money (whether the valuation counts the new cash; post-money = pre-money plus the round), and SAFE caps (which are conversion ceilings, not appraisals). The pre-money vs post-money calculator shows how each choice changes your dilution.
The Valuation Methods by Stage
| Stage | Method that actually governs | 2026 output range |
|---|---|---|
| Pre-seed | Stage norms + team quality ("scorecard") | $3M - $8M cap |
| Seed | Comparables + early revenue multiple | $10M - $25M post |
| Series A | Forward revenue multiple | 15x - 30x ARR |
| Series B+ | Growth-adjusted multiples, cohort economics | Category-dependent |
Pre-seed: stage norms plus adjustments
Formal methods (Berkus, scorecard) dress up what actually happens: investors start from the going rate for their stage and adjust for team, traction signal, and category heat. Repeat founder in a hot category: top of the band or above. First-time founder pre-launch: bottom. Your leverage is evidence and competing interest, not spreadsheet theater.
Seed: comparables begin to bite
With early revenue, investors triangulate: what did similar companies at similar traction raise at recently? A $30K MRR B2B SaaS growing 15 percent monthly prices differently from the same MRR flat. This is where your metric definitions and cohort honesty start affecting price directly.
Series A: the multiple era begins
B2B software Series A rounds price at roughly 15x to 30x current ARR in 2026, with the multiple set by growth rate, net revenue retention, gross margin, and category. AI-native companies with real usage clear the top of the band; slow growers fall below it. The full metrics bar lives in our Series A guide.
The methods that do not apply
DCF and asset-based valuation, the methods every finance textbook opens with, are near-useless before predictable cash flows. If an investor runs a DCF on your seed round, they are producing negotiation theater. Smile and return to comparables.
What Moves Your Multiple in 2026
- Growth rate above all. 3x year-over-year growth can double the multiple 60 percent growth earns. Investors pay for the slope, not the point.
- Retention as truth serum. Net revenue retention above 110 percent signals the product compounds without new sales spend. Below 90 percent caps your price regardless of growth.
- Efficiency joined the equation. Burn multiple under 2 supports premium pricing; burning $3 for every $1 of new ARR discounts it.
- Category heat is real and unfair. AI infrastructure prices above vertical SaaS at identical metrics. You cannot argue with the tide; you can time it and position honestly within it.
- Competition for the deal dominates everything. Two term sheets move price more than every metric combined. A batched process (see below) is a valuation strategy.
Do the Math Before Investors Do It to You
Round Funded's free calculators run the standard models with your inputs:
- Startup valuation calculator: stage norms and multiple-based estimates from your numbers
- Pre-money vs post-money calculator: what any given valuation means for dilution
- Cap table calculator: how SAFEs and the option pool compound across rounds
- Funding goal calculator: size the raise the valuation must support
How to Set Your Valuation: Step by Step
- Anchor with data via Round Funded. Run the calculator, then sanity-check against your stage band and 5 to 10 recent comparable rounds in your category.
- Price the round off dilution, not ego. Decide the raise size first (18 to 24 months of milestones), then accept 15 to 25 percent dilution at pre-seed and seed. The valuation falls out of that arithmetic.
- Stack your evidence. Growth rate, retention, efficiency, and category proof points, presented in a clean data room. Evidence moves you within the band; nothing moves you far outside it.
- Never name the number first. Say "we expect the market to price this" and let term sheets speak. Naming a low number caps you; naming a high one filters you before evidence gets seen.
- Manufacture competition. Batch your investor outreach so 40 to 60 qualified funds hit decision points the same fortnight. Competition is the only reliable above-band lever.
- Take the better partner over the extra 15 percent. A $12M vs $14M cap changes your exit outcome trivially; a board member who blocks your next round changes it existentially.
Frequently Asked Questions
How do you value a startup with no revenue?
By stage norms adjusted for team and evidence: 2026 pre-seed rounds price at $3M to $8M caps, with repeat founders and hot categories at the top. Formal frameworks like scorecard exist, but comparable recent deals govern. Estimate yours with the valuation calculator.
What revenue multiple do startups get in 2026?
B2B software Series A rounds price at roughly 15x to 30x current ARR, with growth rate, retention, and category setting the position in the band. AI-native companies clear premiums above it. Seed-stage revenue is triangulated against comparables rather than strictly multiplied.
What is the difference between pre-money and post-money valuation?
Pre-money is the company's price before the new investment; post-money adds the round: raise $2M at $8M pre-money and the post-money is $10M, selling 20 percent. Every dilution consequence flows from this; the calculator makes it concrete.
Is a SAFE valuation cap the same as a valuation?
No. A cap is the maximum conversion price for that investor, not a priced appraisal of the company. Investors do read caps as market signals though, so absurd caps still kill conversations. The mechanics are in our SAFE guide.
Should I name my valuation to investors?
Avoid naming it first. State your raise amount, let the process generate term sheets, and let competition price the round. If pushed, give the dilution frame: "we plan to sell 15 to 20 percent of the company this round."
Can my valuation be too high?
Yes, and it bites at the next round. A seed priced above your metrics forces you to grow into it or face a flat or down Series A, which reads as failure to new investors and crushes morale. Bands exist because the next round remembers.
What makes investors pay a premium valuation?
Competing term sheets, exceptional growth with strong retention, category heat, and scarce founder-market fit, roughly in that order. Everything except competition is built before the raise; competition is built by running a tight process across a well-filtered investor list.
Price Is an Output, Not an Input
Your valuation falls out of stage, evidence, and competition. Control the three inputs, run the math yourself before anyone runs it at you, and negotiate from arithmetic instead of hope.
Start with the free valuation calculator →
Know your number before the meeting does. Run it on Round Funded.
